Univariate analysis of predictors for hyperautofluorescent ring presence after first treatment cycle
| Ring presence | Baseline SRF area (mm2) | Time to first treatment | No. of anti-VEGF injections | Duration until dry (days) |
|---|---|---|---|---|
| Yes | 7.40 | 16.76 | 5.36 | 156 |
| No | 2.86 | 6.26 | 4.07 | 113 |
| p Value (for log odds of N/Y) | 0.0113* | 0.2937 | 0.0439* | 0.1192 |
*Statistical significance.
SRF, subretinal fluid; VEGF, vascular endothelial growth factor.